Coherus BioSciences Inc (CHRS)
1.93
-0.09
(-4.46%)
USD |
NASDAQ |
Apr 25, 16:00
1.96
+0.03
(+1.55%)
After-Hours: 07:53
Coherus BioSciences Total Liabilities (Quarterly): 823.03M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 823.03M |
| September 30, 2023 | 717.38M |
| June 30, 2023 | 644.36M |
| March 31, 2023 | 598.93M |
| December 31, 2022 | 618.26M |
| September 30, 2022 | 648.04M |
| June 30, 2022 | 568.63M |
| March 31, 2022 | 580.82M |
| December 31, 2021 | 581.61M |
| September 30, 2021 | 610.97M |
| June 30, 2021 | 583.32M |
| March 31, 2021 | 565.63M |
| December 31, 2020 | 560.68M |
| September 30, 2020 | 548.00M |
| June 30, 2020 | 543.23M |
| March 31, 2020 | 309.26M |
| December 31, 2019 | 303.71M |
| September 30, 2019 | 271.36M |
| June 30, 2019 | 244.44M |
| March 31, 2019 | 224.63M |
| Date | Value |
|---|---|
| December 31, 2018 | 138.06M |
| September 30, 2018 | 129.07M |
| June 30, 2018 | 126.48M |
| March 31, 2018 | 131.55M |
| December 31, 2017 | 132.08M |
| September 30, 2017 | 134.85M |
| June 30, 2017 | 141.39M |
| March 31, 2017 | 150.54M |
| December 31, 2016 | 159.13M |
| September 30, 2016 | 160.64M |
| June 30, 2016 | 313.05M |
| March 31, 2016 | 293.11M |
| December 31, 2015 | 219.31M |
| September 30, 2015 | 162.27M |
| June 30, 2015 | 153.18M |
| March 31, 2015 | 115.16M |
| December 31, 2014 | 120.46M |
| September 30, 2014 | 120.00M |
| June 30, 2014 | 107.61M |
| December 31, 2013 | 89.83M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
244.44M
Minimum
Jun 2019
823.03M
Maximum
Dec 2023
543.25M
Average
580.82M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| AbbVie Inc | 124.31B |
| Inovio Pharmaceuticals Inc | 53.60M |
| Nektar Therapeutics | 267.05M |
| Avid Bioservices Inc | 275.06M |
| Stereotaxis Inc | 19.99M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 629.60M |
| Shareholders Equity (Quarterly) | -193.42M |
| Debt to Equity Ratio | -2.447 |
| Current Ratio | 1.434 |
| Net Debt Paydown Yield | -0.15% |